HOME >> BIOLOGY >> NEWS
Microbes active in Colorado snows fuel tundra ecosystem

Arlington, Va.--Populations of fungi blanketed by Colorado's snows are more active and diverse than previously thought, and are likely responsible for the productivity of the tundra ecosystem they are a part of, according to findings by scientists funded through the National Science Foundation (NSF)'s Long-Term Ecological Research (LTER) and Microbial Observatories programs. The researchers have published their results in this week's issue of the journal Science.

Christopher Schadt, now of the Department of Energy's Oak Ridge National Laboratory in Tennessee and a former graduate student at the University of Colorado at Boulder, said "the discovery should help scientists gain greater insight into decomposition rates, carbon cycles and the roles of individual fungi in those processes." Surprisingly, the number of active microorganisms in tundra soils, for at least the top 10 centimeters, (about four inches) peaks when the soils are covered with snow. Schadt and colleagues performed their research at the Niwot Ridge, Colo., LTER site. Niwot Ridge is located some 12,000 feet atop the Rocky Mountains.

"The finding that microorganisms are interacting with tundra soils to a great extent highlights the important role of the snowpack in creating a unique and crucial environment in tundra ecosystems in Colorado and likely in other locations that are covered with snow for long periods of time in winter," said Henry Gholz, LTER program director at NSF.

Metabolism of snow-covered microbes is an important biogeochemical "sink," or way of storing, nitrogen. "The subsequent release in spring of nitrogen from the microbes' metabolism is a major contributor to the relatively high productivity during the short growing season in the tundra," said Steven Schmidt of the University of Colorado at Boulder, a co-author of the Science paper, and leader of the research team.

Schadt, Schmidt, and colleagues Andrew Martin of the University of Colorad
'"/>

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation
4-Sep-2003


Page: 1 2

Related biology news :

1. Microbes eat their way to better concrete
2. Microbes found in Mayan ruins may deteriorate stone from inside out
3. Microbes blueprints promise insights into oceans, more
4. Microbes related to infant lung infections reduced using specialized ventilation system device
5. Microbes and the dust they ride in on pose potential health risks
6. "Microbes deep within South African gold mines" subject of NSF lecture
7. Microbes make mine-waste drinkable, Science researchers report
8. Microbes on Earth may be key to identifying life on other planets
9. Microbes in basalt thrive on mixed diet of toxic waste
10. Microbes work magic on hazardous air pollutants
11. Chemical Reaction Believed To Support Underground Microbes Is Now Unlikely

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Microbes active Colorado snows fuel tundra ecosystem

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: